Iovance Biotherapeutics Inc (IOVA)
8.08
-0.08
(-0.98%)
USD |
NASDAQ |
Jun 17, 16:00
8.08
0.00 (0.00%)
After-Hours: 16:02
Iovance Biotherapeutics Cash from Operations (Quarterly): -122.28M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -122.28M |
| December 31, 2023 | -83.97M |
| September 30, 2023 | -84.08M |
| June 30, 2023 | -93.95M |
| March 31, 2023 | -99.82M |
| December 31, 2022 | -77.67M |
| September 30, 2022 | -63.65M |
| June 30, 2022 | -77.64M |
| March 31, 2022 | -73.80M |
| December 31, 2021 | -53.85M |
| September 30, 2021 | -57.69M |
| June 30, 2021 | -54.01M |
| March 31, 2021 | -62.39M |
| December 31, 2020 | -62.69M |
| September 30, 2020 | -40.52M |
| June 30, 2020 | -36.64M |
| March 31, 2020 | -65.29M |
| December 31, 2019 | -53.82M |
| September 30, 2019 | -42.18M |
| June 30, 2019 | -33.80M |
| March 31, 2019 | -29.09M |
| December 31, 2018 | -31.55M |
| September 30, 2018 | -27.93M |
| June 30, 2018 | -23.92M |
| March 31, 2018 | -17.85M |
| Date | Value |
|---|---|
| December 31, 2017 | -20.96M |
| September 30, 2017 | -21.45M |
| June 30, 2017 | -17.50M |
| March 31, 2017 | -18.80M |
| December 31, 2016 | -12.16M |
| September 30, 2016 | -12.21M |
| June 30, 2016 | -3.748M |
| March 31, 2016 | -4.552M |
| December 31, 2015 | -6.58M |
| September 30, 2015 | -3.842M |
| June 30, 2015 | -4.50M |
| March 31, 2015 | -3.459M |
| December 31, 2014 | -3.315M |
| September 30, 2014 | -1.728M |
| June 30, 2014 | -1.322M |
| March 31, 2014 | -2.267M |
| December 31, 2013 | -2.252M |
| September 30, 2013 | -0.4271M |
| June 30, 2013 | -0.6819M |
| March 31, 2013 | -0.30M |
| December 31, 2012 | 0.00 |
| September 30, 2012 | -0.2807M |
| June 30, 2012 | -1.200M |
| March 31, 2012 | -0.7602M |
| December 31, 2011 | -2.710M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-122.28M
Minimum
Mar 2024
-33.80M
Maximum
Jun 2019
-66.99M
Average
-63.17M
Median
Cash from Operations (Quarterly) Benchmarks
| Viatris Inc | 614.60M |
| Beam Therapeutics Inc | -99.75M |
| Revolution Medicines Inc | -160.56M |
| Day One Biopharmaceuticals Inc | -49.73M |
| Viking Therapeutics Inc | -6.134M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -111.51M |
| Cash from Financing (Quarterly) | 193.58M |
| Free Cash Flow | -405.08M |
| Free Cash Flow Per Share (Quarterly) | -0.475 |
| Free Cash Flow to Equity (Quarterly) | -126.45M |
| Free Cash Flow to Firm (Quarterly) | -126.45M |
| Free Cash Flow Yield | -20.20% |